GB0325603D0 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- GB0325603D0 GB0325603D0 GBGB0325603.9A GB0325603A GB0325603D0 GB 0325603 D0 GB0325603 D0 GB 0325603D0 GB 0325603 A GB0325603 A GB 0325603A GB 0325603 D0 GB0325603 D0 GB 0325603D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0325603.9A GB0325603D0 (en) | 2003-11-03 | 2003-11-03 | Organic compounds |
| BRPI0416109-2A BRPI0416109A (en) | 2003-11-03 | 2004-11-03 | process for preparing clopidogrel compositions |
| EP04797570A EP1682096A1 (en) | 2003-11-03 | 2004-11-03 | Process for preparing clopidogrel compositions |
| JP2006537245A JP2007527414A (en) | 2003-11-03 | 2004-11-03 | Method for producing clopidogrel composition |
| AU2004290511A AU2004290511A1 (en) | 2003-11-03 | 2004-11-03 | Process for preparing clopidogrel compositions |
| PCT/EP2004/012437 WO2005048992A1 (en) | 2003-11-03 | 2004-11-03 | Process for preparing clopidogrel compositions |
| CN200480032288A CN101848705A (en) | 2003-11-03 | 2004-11-03 | Process for preparing clopidogrel compositions |
| CA002540965A CA2540965A1 (en) | 2003-11-03 | 2004-11-03 | Process for preparing clopidogrel compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0325603.9A GB0325603D0 (en) | 2003-11-03 | 2003-11-03 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0325603D0 true GB0325603D0 (en) | 2003-12-10 |
Family
ID=29725839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0325603.9A Ceased GB0325603D0 (en) | 2003-11-03 | 2003-11-03 | Organic compounds |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1682096A1 (en) |
| JP (1) | JP2007527414A (en) |
| CN (1) | CN101848705A (en) |
| AU (1) | AU2004290511A1 (en) |
| BR (1) | BRPI0416109A (en) |
| CA (1) | CA2540965A1 (en) |
| GB (1) | GB0325603D0 (en) |
| WO (1) | WO2005048992A1 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005070464A2 (en) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of clopidogrel bisulphate |
| AU2005236034A1 (en) * | 2004-04-20 | 2005-11-03 | Sanofi-Aventis | Polymorphic forms of methyl (+) - (S) -alpha- (2-chlorophenyl) -6, 7-dihydrothieno [3,2-c]pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide |
| CA2561006A1 (en) | 2004-04-20 | 2005-11-03 | Sanofi-Aventis | Clopidogrel salt and polymorphic forms thereof |
| JP2008526896A (en) * | 2005-02-24 | 2008-07-24 | テバ ファーマシューティカル インダストリーズ リミティド | Glopidogrel base suitable for pharmaceutical formulation and its preparation |
| DE202005013839U1 (en) * | 2005-09-01 | 2005-10-27 | Helm Ag | Tablet containing monobasic acid salt of clopidogrel, useful for preventing thromboembolic events, e.g. stroke or myocardial infarction, contains no ionic or basic auxiliaries or polyethylene glycol |
| WO2007054968A2 (en) * | 2005-09-20 | 2007-05-18 | Torrent Pahrmaceuticals Limited | Novel pharmaceutical compositions of clopidogrel mesylate |
| IS2385B (en) * | 2006-02-10 | 2008-07-15 | Actavis Group Hf. | Clopidogrel bisulfate pharmaceutical compositions |
| CZ298349B6 (en) * | 2006-03-09 | 2007-09-05 | Zentiva, A. S | Hydrogen bromide clopidogrel pharmaceutical composition |
| JP2009532462A (en) * | 2006-04-05 | 2009-09-10 | カディラ・ヘルスケア・リミテッド | Modified release clopidogrel formulation |
| EP1847258B2 (en) | 2006-04-13 | 2013-01-16 | Acino Pharma AG | Partial glycerides as lubricants in pharmaceutical compositions comprising thieno[3,2-c]pyridine derivatives |
| DE502006005452D1 (en) * | 2006-04-13 | 2010-01-07 | Rentschler Pharma Gmbh | Poloxamers as lubricants for pharmaceutical compositions containing ThienoÄ3,2-cpyridine derivatives |
| WO2007128476A1 (en) * | 2006-05-04 | 2007-11-15 | Sandoz Ag | Pharmaceutical compositions containing clopidogrel hydrochloride |
| KR20080055356A (en) * | 2006-12-15 | 2008-06-19 | 에스케이케미칼주식회사 | Clopidogrel-containing clathrate composite with excellent storage stability |
| KR20080055355A (en) * | 2006-12-15 | 2008-06-19 | 에스케이케미칼주식회사 | Clopidogrel-containing clathrate composite with excellent storage stability |
| EP1970054A3 (en) | 2007-03-14 | 2009-06-03 | Ranbaxy Laboratories Limited | Clopidogrel tablets |
| WO2008129468A2 (en) * | 2007-04-20 | 2008-10-30 | Wockhardt Research Centre | Pharmaceutical compositions of clopidogrel |
| EP2095815B1 (en) * | 2008-02-26 | 2011-10-26 | Laboratorios Lesvi, S.L. | Pharmaceutical formulations containing clopidogrel |
| EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
| ATE482961T1 (en) | 2008-04-25 | 2010-10-15 | Sandoz Ag | HYDROGEN SULFATE OF 2-ACETOXY-5-(A-CYCLOPROPYLCARBONYL-2-FLUORBENZYL)-4,5,6,7-TETRAHYDROTHIENOÄ3,2-CUPYRIDINE AND PREPARATION THEREOF |
| WO2010094471A1 (en) | 2009-02-17 | 2010-08-26 | Krka, D. D., Novo Mesto | Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
| JP2013032289A (en) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | Wax stable formulation |
| ES2363964B1 (en) | 2009-11-20 | 2012-08-22 | Gp Pharm, S.A. | CAPSULES OF PHARMACEUTICAL ACTIVE PRINCIPLES AND ESTERS OF POLYINSATURATED FATTY ACIDS. |
| CN101766573B (en) | 2010-02-05 | 2013-02-13 | 上海安必生制药技术有限公司 | Preparation process of clopidogrel bisulfate solid preparation |
| CN101851247B (en) * | 2010-06-04 | 2013-05-29 | 浙江华海药业股份有限公司 | Composition containing clopidogrel bisulfate crystal particles |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2363053C (en) * | 2001-11-09 | 2011-01-25 | Bernard Charles Sherman | Clopidogrel bisulfate tablet formulation |
| WO2004074215A1 (en) * | 2003-02-03 | 2004-09-02 | Sunil Sadanand Nadkarni | Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
-
2003
- 2003-11-03 GB GBGB0325603.9A patent/GB0325603D0/en not_active Ceased
-
2004
- 2004-11-03 CN CN200480032288A patent/CN101848705A/en active Pending
- 2004-11-03 BR BRPI0416109-2A patent/BRPI0416109A/en not_active Application Discontinuation
- 2004-11-03 EP EP04797570A patent/EP1682096A1/en not_active Withdrawn
- 2004-11-03 AU AU2004290511A patent/AU2004290511A1/en not_active Abandoned
- 2004-11-03 JP JP2006537245A patent/JP2007527414A/en not_active Withdrawn
- 2004-11-03 WO PCT/EP2004/012437 patent/WO2005048992A1/en not_active Ceased
- 2004-11-03 CA CA002540965A patent/CA2540965A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101848705A (en) | 2010-09-29 |
| BRPI0416109A (en) | 2007-01-02 |
| AU2004290511A1 (en) | 2005-06-02 |
| JP2007527414A (en) | 2007-09-27 |
| EP1682096A1 (en) | 2006-07-26 |
| CA2540965A1 (en) | 2005-06-02 |
| WO2005048992A1 (en) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0301259D0 (en) | Organic compounds | |
| GB0303503D0 (en) | Organic compounds | |
| GB0325603D0 (en) | Organic compounds | |
| GB0306715D0 (en) | Organic compounds | |
| GB0302876D0 (en) | Organic compounds | |
| GB0300095D0 (en) | Organic compounds | |
| GB0302748D0 (en) | Organic compounds | |
| GB0301938D0 (en) | Organic compounds | |
| GB0301471D0 (en) | Organic compounds | |
| GB0303506D0 (en) | Organic compounds | |
| GB0310868D0 (en) | Organic compounds | |
| GB0306070D0 (en) | Organic compounds | |
| GB0306071D0 (en) | Organic compounds | |
| GB0320637D0 (en) | Organic compounds | |
| GB0302991D0 (en) | Organic compounds | |
| GB0307277D0 (en) | Organic compounds | |
| GB0307440D0 (en) | Organic compounds | |
| GB0302750D0 (en) | Organic compounds | |
| GB0305154D0 (en) | Organic compounds | |
| GB0303095D0 (en) | Organic compounds | |
| GB0303323D0 (en) | Organic compounds | |
| GB0303867D0 (en) | Organic compounds | |
| GB0302874D0 (en) | Organic compounds | |
| GB0318100D0 (en) | Organic compounds | |
| GB0302749D0 (en) | Organic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| COOA | Change in applicant's name or ownership of the application |
Owner name: SANDOZ AG Free format text: FORMER APPLICANT(S): SANDOZ GMBH |
|
| AT | Applications terminated before publication under section 16(1) |